Achyut Healthcare Ltd
₹ 3.80
-4.76%
23 Dec
- close price
About
Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, Pharmaceutical products, medical devices, etc.[1]
Key Points
- Market Cap ₹ 89.5 Cr.
- Current Price ₹ 3.80
- High / Low ₹ 6.25 / 2.87
- Stock P/E 136
- Book Value ₹ 1.32
- Dividend Yield 0.00 %
- ROCE 3.27 %
- ROE 2.52 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 2.88 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.15% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
0.67 | 0.33 | 0.27 | 4.05 | 2.70 | 6.14 | 6.78 | |
0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 6.12 | 6.87 | |
Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 | -0.09 |
OPM % | 1.49% | 3.03% | 3.70% | -0.74% | -10.00% | 0.33% | -1.33% |
-0.00 | 0.01 | -0.00 | 0.14 | 0.59 | 0.73 | 0.97 | |
Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Depreciation | -0.00 | -0.00 | -0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Profit before tax | 0.01 | 0.02 | 0.01 | 0.10 | 0.31 | 0.74 | 0.87 |
Tax % | 300.00% | -0.00% | -0.00% | 60.00% | 25.81% | 22.97% | |
-0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.57 | 0.66 | |
EPS in Rs | -0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.02 |
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 56% |
3 Years: | 183% |
TTM: | 196% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 126% |
3 Years: | 285% |
TTM: | 164% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 2% |
Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 16.83 | 16.83 |
Reserves | -0.05 | -0.04 | -0.00 | 2.34 | 5.18 | 13.93 | 14.28 |
-0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.19 | 0.82 | |
Total Liabilities | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 31.93 |
-0.00 | -0.00 | -0.00 | 0.03 | 0.05 | 0.06 | 0.05 | |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | 3.49 | 9.16 | 13.97 |
Investments | -0.00 | -0.00 | -0.00 | 1.70 | 1.30 | -0.00 | -0.00 |
0.24 | 0.27 | 0.50 | 8.21 | 10.50 | 21.73 | 17.91 | |
Total Assets | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 31.93 |
Cash Flows
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-0.03 | -0.02 | 0.01 | -6.96 | -0.43 | -0.36 | |
-0.00 | -0.00 | -0.00 | -1.60 | -4.81 | -15.23 | |
-0.00 | -0.00 | -0.00 | 8.79 | 5.21 | 15.72 | |
Net Cash Flow | -0.03 | -0.02 | 0.01 | 0.24 | -0.03 | 0.14 |
Ratios
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 54.48 | 188.03 | 378.52 | 18.02 | 36.50 | 24.37 |
Inventory Days | -0.00 | -0.00 | 158.70 | 14.29 | 59.59 | 3.96 |
Days Payable | 380.87 | 41.78 | 55.87 | 9.24 | ||
Cash Conversion Cycle | 54.48 | 188.03 | 156.34 | -9.46 | 40.22 | 19.09 |
Working Capital Days | 76.27 | 210.15 | 216.30 | 603.83 | 1,257.22 | 1,242.43 |
ROCE % | 9.76% | 4.35% | 2.14% | 2.63% | 3.27% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment
11 Dec - Allotment of 6.73 crore bonus shares in 4:10 ratio.
-
Board Meeting Outcome for Allotment Of Bonus Shares
11 Dec - Allotment of 6.73 crore bonus equity shares.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
22 Nov - Voting results of Extra Ordinary General Meeting.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
22 Nov - Voting results of Extra Ordinary General Meeting.
- Corporate Action- Record Dates For Sub Division Of Shares And Bonus Issue 20 Nov
Business Overview:[1]
Company is in the manufacturing of
pharmaceutical formulations in the
forms of Tablets, Capsules, Oral liquid
and Injectables.